These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14508205)

  • 41. Antiproteinuric effect of cilnidipine in hypertensive Japanese treated with renin-angiotensin-system inhibitors - a multicenter, open, randomized trial using 24-hour urine collection.
    Miwa Y; Tsuchihashi T; Ohta Y; Tominaga M; Kawano Y; Sasaguri T; Ueno M; Matsuoka H
    Clin Exp Hypertens; 2010; 32(6):400-5. PubMed ID: 20828221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Phase III, double-blind, parallel-group controlled study of amlodipine 10 mg once daily in Japanese patients with essential hypertension who insufficiently responded to amlodipine 5 mg once daily.
    Fujiwara T; Ii Y; Hatsuzawa J; Murase H; Watanabe T; Murakami M; Kimura N; Buch J; Tsuchihashi T; Saruta T
    J Hum Hypertens; 2009 Aug; 23(8):521-9. PubMed ID: 19148107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lercanidipine in the treatment of hypertension.
    Beckey C; Lundy A; Lutfi N
    Ann Pharmacother; 2007 Mar; 41(3):465-73. PubMed ID: 17341540
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Switching patients with uncontrolled hypertension on amlodipine 10 mg to single-pill combinations of telmisartan and amlodipine: results of the TEAMSTA-10 study.
    Neldam S; Edwards C; Jones R;
    Curr Med Res Opin; 2011 Nov; 27(11):2145-53. PubMed ID: 21955225
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of enalapril/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients.
    Derosa G; Bonaventura A; Romano D; Bianchi L; Fogari E; D'Angelo A; Maffioli P
    J Clin Pharm Ther; 2014 Jun; 39(3):277-85. PubMed ID: 24635387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Renal protection with calcium antagonists: the role of lercanidipine.
    Burnier M
    Curr Med Res Opin; 2013 Dec; 29(12):1727-35. PubMed ID: 24069902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of azelnidipine on home blood pressure and pulse rate in patients with essential hypertension: comparison with amlodipine.
    Yamagishi T
    Hypertens Res; 2006 Oct; 29(10):767-73. PubMed ID: 17283863
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of the treatment: combination of benazepril/lercanidipine vs. benazepril alone in patients with mild-to-moderate hypertension.
    Chen T; Chen GH; Yang TS; Zhong ZY; An WS; Zhang XX; Li JD
    Chin Med J (Engl); 2013 Jun; 126(12):2286-90. PubMed ID: 23786940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of calcium antagonists on stress-induced rise in blood pressure and heart rate: a double-blind, placebo-controlled study.
    Malhotra S; Kumari S; Pandhi P
    Int J Clin Pharmacol Ther; 2001 Jan; 39(1):19-24. PubMed ID: 11204933
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy.
    Motoki H; Koyama J; Izawa A; Tomita T; Miyashita Y; Takahashi M; Ikeda U
    Echocardiography; 2014 Nov; 31(10):1230-8. PubMed ID: 24645985
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
    Fogari R; Preti P; Lazzari P; Corradi L; Zoppi A; Fogari E; Mugellini A
    Eur J Clin Pharmacol; 2003 Aug; 59(4):271-5. PubMed ID: 12830340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension.
    De Ciuceis C; Salvetti M; Paini A; Rossini C; Muiesan ML; Duse S; Caletti S; Coschignano MA; Semeraro F; Trapletti V; Bertacchini F; Brami V; Petelca A; Agabiti Rosei E; Rizzoni D; Agabiti Rosei C
    Intern Emerg Med; 2017 Oct; 12(7):963-974. PubMed ID: 28647890
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and safety evaluation of lacidipine compared with amlodipine in mild-to-moderate hypertensive patients.
    Lombardo D; Raimondi F
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S98-100. PubMed ID: 7609517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-related difference in the sleep pressure-lowering effect between an angiotensin II receptor blocker and a calcium channel blocker in Asian hypertensives: the ACS1 Study.
    Kario K; Hoshide S
    Hypertension; 2015 Apr; 65(4):729-35. PubMed ID: 25646296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Once-daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J; Robb OJ; Jeffers TA; Scott AK; Petrie JC
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S72-5. PubMed ID: 2467134
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lercanidipine in hypertension.
    Borghi C
    Vasc Health Risk Manag; 2005; 1(3):173-82. PubMed ID: 17319103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Once daily amlodipine in the treatment of mild to moderate hypertension.
    Webster J; Robb OJ; Jeffers TA; Scott AK; Petrie JC; Towler HM
    Br J Clin Pharmacol; 1987 Dec; 24(6):713-9. PubMed ID: 2964253
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
    Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.